News
6d
News-Medical.Net on MSNAI-designed drug shows early promise for lung fibrosis patients in clinical trialResearchers report that rentosertib, an AI-discovered TNIK inhibitor, showed promising safety and potential to improve lung function in patients with idiopathic pulmonary fibrosis in a 12-week phase ...
Furthermore, we demonstrated that the learned compensatory mechanism contributing to associative morphine tolerance requires an action of CCK at the CCK-B receptor in the L/BL amygdala.
THE unravelling of the arrangement and complications of the nervous system has always been of great interest not only to physiologists, but also to mankind in general. The specially human ...
A challenging treatment landscape Although drugs such as Roche’s Esbriet (pirfenidone ... that occurs through COVID may have a different mechanism, there have been calls for research into ...
Currently approved treatments are Ofev and Roche's kinase inhibitor Esbriet (pirfenidone) – the latter now available in generic form – which have also been shown to slow down the decline in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results